Skip to main content

Advertisement

Log in

The roles of IL-2 and IL-10 enhance anti-CD45RBmAb immune inhibition in allograft skin

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

As a new type of immune tolerance inducer, anti-CD45RB monoclonal antibodies (anti-CD45RBmAb) can prolong the graft survival time of animal organs or cell transplantation as well as induce stable immune tolerance. Both interleukin (IL)-2 and IL-10 have important roles in the induction and maintenance of immunological tolerance. However, whether these cytokines combined with anti-CD45RBmAb can promote immune tolerance is poorly understood. Therefore, we investigated the effect of IL-2 and IL-10 in vitro and in vivo on the tolerance induction by anti-CD45RBmAb. The changes of Treg and Th17 cells and Th1/Th2 cytokines in anti-CD45RBmAb induced prolongation of skin allograft survival in mice. The finding of a role for IL-2 is novel, of interest, IL-2 promoted anti-CD45RBmAb-induced CD4+ T cell differentiation into Treg and Th2 cells and suppressed Th17 and Th1 cells. IL-2 enhanced the induction of immune tolerance by anti-CD45RBmAb and significantly prolonged skin graft survival time in vivo. In contrast, this effect should be demonstrated experimentally by neutralizing IL-2 and inhibition of the effect of anti-CD45RBmAb, and neutralizing IL-10 showed no effect for anti-CD45RBmAb-induced tolerance. These data reveal that IL-2 significantly enhances anti-CD45RBmAb-induced immune tolerance via up-regulated T regulatory (Treg) cells and the balance of Th1/Th2 shifts. Conversely, IL-10 showed no effect on anti-CD45RBmAb-induced tolerance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Davies JD, O’Connor E, Hall D, Krahl T, Trotter J, Sarvetnick N. CD4+CD45RB low-density cells from untreated mice prevent acute allograft rejection. J Immunol. 1999;163:5353–7.

    CAS  PubMed  Google Scholar 

  2. Luke PP, Deng JP, Lian D, O’Connell PJ, Garcia B, Jevnikar AM, Zhong R. Prolongation of allograft survival by administration of anti-CD45RBmAb monoclonal antibody is due to alteration of CD45RBhi: CD45RBlo T-Cell proportions. Am J Transplant. 2006;6:2023–34.

    Article  CAS  PubMed  Google Scholar 

  3. Lazarovits AI, Poppema S, Zhang Z, Khandaker M, Le Feuvre CE, Singhal SK, Garcia BM, Ogasa N, Jevnikar AM, White MH, Singh G, Stiller CR, Zhong RZ. Prevention and reversal of renal allograft rejection by antibody against CD45RB. Nature. 1996;380:717–20.

    Article  CAS  PubMed  Google Scholar 

  4. Lee KM, Yeh H, Zhao G, Wei L, O’Connor M, Stott RT, Soohoo J, Dunussi K, Fiorina P, Deng S, Markmann JF, Kim JI. B-cell depletion improves islet allograft survival with anti-CD45RB. Cell Transplant. 2014;23(1):51–8.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Basadonna GP, Auersvald L, Khuong CQ, Zheng XX, Kashio N, Zekzer D, Minozzo M, Qian H, Visser L, Diepstra A, Lazarovits AI, Poppema S, Strom TB, Rothstein DM. Antibody-mediated targeting of CD45 isoforms: a novel immunotherapeutic strategy. Proc Natl Acad Sci. 1998;95:3821–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Sho M, Harada H, Rothstein DM, Sayegh MH. CD45RB-targeting strategies for promoting long-term allograft survival and preventing chronic allograft vasculopathy. Transplantation. 2003;75:1142–6.

    Article  CAS  PubMed  Google Scholar 

  7. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 is essential for TGF-beta to convert naive CD4+CD25 Cells to CD25+Foxp3+ regulatory T Cells and for expansion of these cells. J Immunol. 2007;178:2018–27.

    Article  CAS  PubMed  Google Scholar 

  8. Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L, Shevach EM, O’shea JJ. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity. 2007;26:371–81.

    Article  CAS  PubMed  Google Scholar 

  9. Piccioni M, Chen Z, Tsun A, Li B. Regulatory T-cell differentiation and their function in immune regulation. Adv Exp Med Biol. 2014;841:67–97.

    Article  PubMed  Google Scholar 

  10. Bellinghausen I, Brand U, Steinbrink K, Enk AH, Knop J, Saloga J. Inhibition of human allergic T-cell responses by IL-10–treated dendritic cells: differences from hydrocortisone-treated dendritic cells. J Allergy Clin Immunol. 2001;108:242–9.

    Article  CAS  PubMed  Google Scholar 

  11. Zhao G, Moore DJ, Lee KM, Kim JI, Duff PE, O’Connor MR, Hirohashi T, Lei J, Yang M, Markmann JF, Deng S. An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance. Am J Transplant. 2010;10:796–801.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  12. Fecteau S, Basadonna GP, Freitas A, Ariyan C, Sayegh MH, Rothstein DM. CTLA-4 up-regulation plays a role in tolerance mediated by CD45. Nat Immunol. 2001;2:58–63.

    Article  CAS  PubMed  Google Scholar 

  13. Ariyan C, Salvalaggio P, Fecteau S, Deng S, Rogozinski L, Mandelbrot D, Sharpe A, Sayegh MH, Basadonna GP, Rothstein DM. Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol. 2003;171:5673–7.

    Article  CAS  PubMed  Google Scholar 

  14. Jen KY, Campo M, He H, Makani SS, Velasco G, Rothstein DM, Perkins DL, Finn PW. CD45RB ligation inhibits allergic pulmonary inflammation by inducing CTLA4 transcription. J Immunol. 2007;179:4212–8.

    Article  CAS  PubMed  Google Scholar 

  15. Deng S, Moore DJ, Huang X, Mohiuddin M, Lee MK IV, Velidedeoglu E, Lian MM, Chiaccio M, Sonawane S, Orlin A, Wang J, Chen H, Caton A, Zhong R, Markmann JF. Antibody-induced transplantation tolerance that is dependent on thymus-derived regulatory T cells. J Immunol. 2006;176:2799–807.

    Article  CAS  PubMed  Google Scholar 

  16. Qi H, Liu JP, Deng CY, Zhou HX, Deng SP, Li FR. A role for anti-CD45RB monoclonal antibody treatment upon dendritic cells. Immunol Res. 2012;52:250–7.

    Article  CAS  PubMed  Google Scholar 

  17. Deng S, Moore DJ, Huang X, Lian MM, Mohiuddin M, Velededeoglu E, Lee MK IV, Sonawane S, Kim J, Wang J, Chen H, Corfe SA, Paige C, Shlomchik M, Caton A, Markmann JF. Cutting edge: transplant tolerance induced by anti-CD45RBmAb requires B lymphocytes. J Immunol. 2007;178:6028–32.

    Article  CAS  PubMed  Google Scholar 

  18. Xia X, Zhang X, Huang X, Ichim TE, Li M, Luke P, Min W. Anti-CD45RBmAb monoclonal antibody induces immunologic toleration by suppressing dendritic cells. Transpl Immunol. 2009;21:136–9.

    Article  CAS  PubMed  Google Scholar 

  19. Langier S, Sade K, Kivity S. Regulatory T cells: the suppressor arm of the immune system. Autoimmun Rev. 2010;10:112–5.

    Article  CAS  PubMed  Google Scholar 

  20. Littman DR, Rudensky AY. Th17 and regulatory T Cells in mediating and restraining inflammation. Cell. 2010;140:845–58.

    Article  CAS  PubMed  Google Scholar 

  21. Anne Arai N. The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 2000;10:542–50.

    Article  Google Scholar 

  22. Schulz EG, Mariani L, Radbruch A, Höfer T. Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-γ and interleukin-12. Immunity. 2009;30:673–83.

    Article  CAS  PubMed  Google Scholar 

  23. Bayer AL, Yu A, Malek TR. function of the IL-2R for thymic and peripheral CD4+CD25+Foxp3+ T regulatory cells. J Immunol. 2007;178:4062–71.

    Article  CAS  PubMed  Google Scholar 

  24. Liao W, Lin JX, Wang L, Li P, Leonard WJ. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat Immunol. 2011;12:551–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Bayer AL, Yu A, Adeegbe D, Malek TR. Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period. J Exp Med. 2005;201:769–77.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Li B, Tian L, Diao Y, Li X, Zhao L, Wang X. Exogenous IL-10 induces corneal transplantation immune tolerance by a mechanism associated with the altered Th1/Th2 cytokine ratio and the increased expression of TGF-β. Mol Med Rep. 2014;9:2245–50.

    CAS  PubMed  Google Scholar 

  27. Furukawa Y, Becker G, Stinn JL, Shimizu K, Libby P, Mitchell RN. Interleukin-10 (IL-10) augments Allograft arterial disease: paradoxical effects of IL-10 in vivo. Am J Pathol. 1999;155:1929–39.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Richters CD, Hoekstra MJ, du Pont JS, Kreis RW, Kamperdijk EW. Immunology of skin transplantation. Clin Dermatol. 2005;23:338–42.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the national 973 special plan of China (No. 2007CB516811), the National Natural Science Foundation of China (No. 30772042), The Natural Science Foundation of Guangdong (No. 6027540) and The Science and Technology Project of Shenzhen (No. 201001005).

Conflict of interest

No competing financial interests exist.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shao-Ping Deng or Fu-Rong Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, WJ., Qi, H., Deng, CY. et al. The roles of IL-2 and IL-10 enhance anti-CD45RBmAb immune inhibition in allograft skin. Immunol Res 61, 250–259 (2015). https://doi.org/10.1007/s12026-014-8618-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-014-8618-9

Keywords

Navigation